ArticleDiabetology & metabolic syndrome2025
Unveiling the impact of bisphenol a exposure on gene expression and immune response in diabetic nephropathy through integrative toxicogenomics and molecular dynamics approaches.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Study on the Potential Mechanism of Bisphenol A-induced Human Diabetic Nephropathy Based on Network Toxicology and Molecular Docking.Endocrine, metabolic & immune disorders drug targets · 2026Article
- Comprehensive Analysis and Experimental Validation of Immune-Related Biomarkers and Immune Microenvironment in Diabetic Nephropathy.Journal of inflammation research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBisphenol A (BPA) exposure has been implicated in various health issues, including diabetic nephropathy (DN). Understanding the molecular mechanisms underlying BPA-induced DN is crucial for developing effective therapeutic strategies.
methodsWe analyzed the dataset GSE96804 to identify differentially expressed genes (DEGs) associated with DN. We intersected these with BPA-related toxicity targets from the Comparative Toxicogenomics Database. Enrichment analyses were performed to elucidate the functional implications of these genes, and machine learning models (LASSO, RF, SVM-RFE) were employed to identify key feature genes. Immune cell infiltration and immune-related pathways were analyzed using the ssGSEA algorithm, and molecular docking simulations were conducted to explore interactions between BPA and key proteins.
resultsOur findings revealed significant enrichment of BPA-related DEGs in critical pathways such as the AGE-RAGE signaling pathway, diabetic cardiomyopathy, and the renin-angiotensin system. Machine learning identified four key genes (ALB, CTSD, GAS6, VDAC1) consistently associated with BPA exposure and DN. Immune cell infiltration analysis indicated altered immune microenvironments in DN, with significant correlations between feature gene expression and immune cell types. Molecular docking and dynamics simulations demonstrated stable interactions between BPA and ALB, highlighting specific amino acid residues critical for binding.
conclusionThis study underscores the significant impact of BPA on gene expression and immune responses in DN. The identified key genes and their interactions with BPA provide valuable insights into the pathophysiological mechanisms of BPA-induced DN, paving the way for future research and potential therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.